Literature DB >> 11888238

Channelopathies can cause epilepsy in man.

Ortrud K Steinlein1.   

Abstract

Idiopathic epilepsies, which account for up to 40% of all epilepsies, are mainly caused by genetic factors. Most idiopathic epilepsies are due to oligogenic or multifactorial rather than monogenetic inheritance. Nevertheless, most of what is known today about the molecular genetics of idiopathic epilepsies has been found by analysing large families with rare monogenetic forms of the disease. For the first time, gene defects can be linked to certain epilepsies. Mutations in the CHRNA4 or CHRNB subunits of the neuronal nicotinic acetylcholine receptor lead to familial nocturnal frontal lobe epilepsy, while defects in the voltage-gated potassium channels KCNQ2 and KCNQ3 have recently been found to cause benign familial neonatal convulsions. The voltage-gated sodium channel subunits SCN1B, SCN1A and SCN2A as well as the GABRG2 subunit of the GABA(A) receptor are involved in the pathology of the newly described syndrome generalized epilepsy with febrile seizures plus. These rare monogenetic epilepsies can serve as models for further genetic analysis of the common forms of idiopathic epilepsies. Copyright 2002 European Federation of Chapters of the International Association for the Study of Pain

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11888238     DOI: 10.1053/eujp.2001.0319

Source DB:  PubMed          Journal:  Eur J Pain        ISSN: 1090-3801            Impact factor:   3.931


  10 in total

Review 1.  Autosomal dominant nocturnal frontal lobe epilepsy--a critical overview.

Authors:  Romina Combi; Leda Dalprà; Maria Luisa Tenchini; Luigi Ferini-Strambi
Journal:  J Neurol       Date:  2004-08       Impact factor: 4.849

2.  Reversal of impaired hippocampal long-term potentiation and contextual fear memory deficits in Angelman syndrome model mice by ErbB inhibitors.

Authors:  Hanoch Kaphzan; Pepe Hernandez; Joo In Jung; Kiriana K Cowansage; Katrin Deinhardt; Moses V Chao; Ted Abel; Eric Klann
Journal:  Biol Psychiatry       Date:  2012-03-03       Impact factor: 13.382

Review 3.  Sodium channel SCN1A and epilepsy: mutations and mechanisms.

Authors:  Andrew Escayg; Alan L Goldin
Journal:  Epilepsia       Date:  2010-09       Impact factor: 5.864

Review 4.  Channeling studies in yeast: yeast as a model for channelopathies?

Authors:  Devin M Wolfe; David A Pearce
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

5.  Genotypic association of exonic LGI4 polymorphisms and childhood absence epilepsy.

Authors:  Wenli Gu; Thomas Sander; Tim Becker; Ortrud K Steinlein
Journal:  Neurogenetics       Date:  2003-09-19       Impact factor: 2.660

6.  Reduced cortical inhibition in a mouse model of familial childhood absence epilepsy.

Authors:  Heneu O Tan; Christopher A Reid; Frank N Single; Philip J Davies; Cindy Chiu; Susan Murphy; Alison L Clarke; Leanne Dibbens; Heinz Krestel; John C Mulley; Mathew V Jones; Peter H Seeburg; Bert Sakmann; Samuel F Berkovic; Rolf Sprengel; Steven Petrou
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-18       Impact factor: 11.205

Review 7.  Mammalian nicotinic acetylcholine receptors: from structure to function.

Authors:  Edson X Albuquerque; Edna F R Pereira; Manickavasagom Alkondon; Scott W Rogers
Journal:  Physiol Rev       Date:  2009-01       Impact factor: 37.312

8.  Amplicon Resequencing Identified Parental Mosaicism for Approximately 10% of "de novo" SCN1A Mutations in Children with Dravet Syndrome.

Authors:  Xiaojing Xu; Xiaoxu Yang; Qixi Wu; Aijie Liu; Xiaoling Yang; Adam Yongxin Ye; August Yue Huang; Jiarui Li; Meng Wang; Zhe Yu; Sheng Wang; Zhichao Zhang; Xiru Wu; Liping Wei; Yuehua Zhang
Journal:  Hum Mutat       Date:  2015-07-24       Impact factor: 4.878

Review 9.  Epilepsy research: a window onto function to and dysfunction of the human brain.

Authors:  Heinz Beck; Christian E Elger
Journal:  Dialogues Clin Neurosci       Date:  2008       Impact factor: 5.986

Review 10.  Personalized Medicine Using Cutting Edge Technologies for Genetic Epilepsies.

Authors:  Sheila Garcia-Rosa; Bianca de Freitas Brenha; Vinicius Felipe da Rocha; Ernesto Goulart; Bruno Henrique Silva Araujo
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.